Further research revealed that silencing CBS hinders Sp1 nuclear translocation, thereby affecting Sp1 binding to the SREBP-1a promoter site
Among Arkansas public school children in 2024, 23% were classified as obese and 17% were classified as overweight
Effect of Liraglutide Therapy on Liver Fat Content in Patients with Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study
The median time from breast cancer diagnosis to GLP-1 RA initiation was 4.3 years (range, 4.4 to 29.5), and the median duration of GLP-1 RA use was 20 months (range, 6-111 months)

(LEA / EHMC) 50:12 Replacement dose vs PED 55:47 Four takeaways 57:46 Episode 4 preview and book pre-order What we cover: How body fat suppresses testosterone at two different points in the HPG axis, and why the loop is self-reinforcing The leptin and Kisspeptin pathway most clinics never address Marks case: a 45-year-old with a 240 ng/dL afternoon draw, no workup, and an immediate prescription Primary versus secondary causes, and why Klinefelter syndrome is the under-recognized one to not miss Weight loss dose-response: how much testosterone climbs on lifestyle alone, with GLP-1 agonists, and after bariatric surgery T4DM: why adding testosterone to a structured weight-loss program produced no extra quality-of-life benefit over placebo One week of sleep restriction drops testosterone by about 15 percent in healthy young men

Pituitary Stimulation & IGF-1 Upregulation The CJC-1295/Ipamorelin combination restores youthful pulsatile GH secretion, which drives downstream IGF-1 production in the liver